These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37323291)

  • 1. Recalcitrant course of bullous pemphigoid indicating coexisting hypereosinophilic syndrome: A case report and literature review.
    Ganji R; Diab R; Mousavi F; Abdollahimajd F
    Clin Case Rep; 2023 Jun; 11(6):e7384. PubMed ID: 37323291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bullous pemphigoid-like rash revealing hypereosinophilic syndrome.
    Khallaayoune M; Sialiti S; Meziane M; Senouci K
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34103306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyshidrosiform Bullous Pemphigoid: Case Reports and Review.
    Cohen PR
    Cureus; 2020 Jan; 12(1):e6630. PubMed ID: 32064205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pemphigoid nodularis triggered by hypereosinophilic syndrome?].
    von Felbert V; Simon D; Braathen L; Hunziker T
    Hautarzt; 2006 May; 57(5):434-6. PubMed ID: 15776281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinib.
    Hofmann SC; Technau K; Müller AM; Lübbert M; Bruckner-Tuderman L
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S68-72. PubMed ID: 17097375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-aggravated Bullous Pemphigoid in a 47-year-old Asian Woman - A Case Report.
    Nelramachandrakumar D; Hariharan H; Nagamanickam S; Chander J SJU
    Curr Drug Saf; 2023; 18(3):379-382. PubMed ID: 35593331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Bullous Pemphigoid: A Single-Center Retrospective Study.
    Moar A; Azzolini A; Tessari G; Schena D; Girolomoni G
    Dermatology; 2021; 237(6):1039-1045. PubMed ID: 33979792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: Bullous pemphigoid arising in a patient with scleroderma and multiple sclerosis.
    Moro F; Mariotti F; Pira A; De Luca N; Didona B; Pagnanelli G; Di Zenzo G
    Front Med (Lausanne); 2022; 9():1055045. PubMed ID: 36569153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Idiopathic hypereosinophilic syndrome and bullous pemphigoid].
    Belgnaoui F; Idrissi M; Benyoussef K; Loudiye T; Bella A; Senouci K; Aouni M; Mansouri F; Heid E; Hassam B
    Ann Dermatol Venereol; 2002 Nov; 129(11):1291-4. PubMed ID: 12514518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trial.
    Chalmers JR; Wojnarowska F; Kirtschig G; Mason J; Childs M; Whitham D; Harman K; Chapman A; Walton S; Schmidt E; Godec TR; Nunn AJ; Williams HC
    Health Technol Assess; 2017 Mar; 21(10):1-90. PubMed ID: 28406394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum.
    Yu-Yang S; Chu-Sung Hu S; Yiao-Lin S
    Acta Dermatovenerol Croat; 2017 Oct; 25(3):255-256. PubMed ID: 29252183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annular bullous pemphigoid: A case report and review of literature.
    Arès S; Lim D; Jung S; Bouffard D; Mereniuk A
    SAGE Open Med Case Rep; 2022; 10():2050313X221093128. PubMed ID: 35495292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bullous Pemphigoid Mimicking Cellulitis.
    Ivyanskiy I; Dave D; Dweik A; Yeary J; Naguib TM
    J Investig Med High Impact Case Rep; 2021; 9():23247096211008585. PubMed ID: 33847152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects.
    Cozzani E; Gasparini G; Burlando M; Drago F; Parodi A
    Autoimmun Rev; 2015 May; 14(5):438-45. PubMed ID: 25617817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urticarial Lesions in a Pregnant Woman.
    Santos-Alarcón S; Benavente-Villegas C; García-Briz I; Moneva-Léniz M; Sanchis-Sánchez C; Mateu-Puchades A
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):71-72. PubMed ID: 29782306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between bullous pemphigoid and hematological diseases: Literature review on mechanistic connections and possible treatments.
    Yang Y; Zhao W; Yang N; Cui S; Jin H; Li L
    Front Immunol; 2023; 14():1155181. PubMed ID: 36969223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of patients with bullous pemphigoid: comparison of classic bullous pemphigoid to non-bullous pemphigoid.
    Ben Mordehai Y; Faibish H; Astman N; Greenberger S; Barzilai A; Baum S
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):161-165. PubMed ID: 31423677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical Bullous Pemphigoid After Linagliptin Intake.
    Dbouk S; Bazzi N; Saad WA; Toribio A; Habre M; Salloum A
    Am J Case Rep; 2021 Sep; 22():e932356. PubMed ID: 34584063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous Pemphigoid Masquerading as Erythrodermic Psoriasis.
    De-Kaa NLP; Adefemi SA; Akuhwa RT; Fikin A; Atabo A
    West Afr J Med; 2022 Dec; 39(12):1319-1323. PubMed ID: 36583972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.